Vascular endothelial growth factor C gene expression is closely related to invasion phenotype in gynecological tumor cells

Gynecologic Oncology

Volumn 82, Issue 1, 2001, Pages 162-166

  Ueda, Masatsugu ^a   Terai, Yoshito ^a   Kumagai, Koji ^a   Ueki, Ken ^a   Yamaguchi, Hiroyuki ^a   Akise, Daisuke ^a   Ueki, Minoru ^a  

^a OSAKA MEDICAL COLLEGE   (Japan)

Author keywords

Angiogenesis; Gynecological tumor cells; Invasion; Vascular endothelial growth factor C

Indexed keywords

VASCULOTROPIN;

ANGIOGENESIS; ARTICLE; CANCER INVASION; CELL MIGRATION; ENDOMETRIUM CANCER; GENE EXPRESSION; HUMAN; HUMAN CELL; METASTASIS; OVARY CANCER; PRIORITY JOURNAL; UTERINE CERVIX CANCER;

EID: 0034936711     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1006/gyno.2001.6229     Document Type: Article

References (34)

1. Clinical applications of research on angiogenesis
2. Vascular permeability factor: A unique regulator of blood vessel function
3. Induction of vascular endothelial growth factor expression by hypoxia and by glucose deficiency in multiple spheroids: Implications for tumor angiogenesis
4. Neovascularization is associated with a switch to the export of b-FGF in the multistep development of fibrosarcoma
5. Immunocytochemical localization of basic fibroblast growth factor in carcinomas and inflammatory lesions of the human digestive tract
6. Vascular endothelial growth factor B, a novel growth factor for endothelial cells
7. A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinase
8. Vascular endothelial growth factor D (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor 2 (Flk1) and VEGF receptor 3 (Flt4)
9. What is the role of vascular endothelial growth factor-related molecules in tumor angiogenesis?
10. Cancer metastasis and angiogenesis: An imbalance of positive and negative regulation
11. Tumor angiogenesis and metastasis: Correlation in invasive breast carcinoma
12. Scatchard analysis of EGF receptor and effects of EGF on growth and TA-4 production of newly established uterine cervical cancer cell line (OMC-1)
13. Establishment and characterization of CA 125 producing cell line (OMC-2) originating from a human endometrial adenocarcinoma
14. Establishment and characterization of a cell line (OMC-3) originating from a human mucinous cystadenocarcinoma of the ovary
15. Characterization of epidermal growth factor (EGF) receptor and biological effect of EGF on human uterine cervical adenocarcinoma cell line OMC-4
16. Establishment and characterization of the human uterine cervical epidermoid cancer cell line
17. Establishment of human uterine cervical cancer cell line and comparative studies between normal and malignant uterine cervical cells in vitro
18. Newly established uterine cervical cancer cell line (SKG-III) with Regan isoenzyme, human chorionic gonadotropin β-subunit, and pregnancy-specific β1-glycoprotein phenotypes
19. Development and characterization of established cell lines from primary and metastatic regions of human endometrial adenocarcinoma
20. Establishment of a human ovarian clear cell carcinoma cell line (RMG-I) and its single cell cloning: With special reference to the stem cell of the tumor
21. A new CA125-like antigen (CA602) recognized by two monoclonal antibodies against a newly established ovarian clear cell carcinoma cell line (RMG-II)
22. Establishment and characterization of a new HPV-negative squamous cell carcinoma cell line (Yumoto) from the human uterine cervix
23. Structure and expression of an integrated human papillomavirus type 16 genome amplified in a cervical carcinoma cell line
24. NUZ-1
25. Differences between cell lines of uterine cervical glassy cell carcinoma and large cell nonkeratinizing squamous cell carcinoma
26. New monoclonal antibody, 1C5, reactive with human cervical adenocarcinoma of the uterus, with immunodiagnostic potential
27. Laminin and fibronectin promote the haptotactic migration of B16 mouse melanoma cells in vitro
28. Stimulatory effects of EGF and TGF-α on invasive activity and 5′-deoxy-5-fluorouridine sensitivity in uterine cervical carcinoma SKG-IIIb cells
29. A rapid in vitro assay for quantitating the invasive potential of tumor cells
30. Vascular endothelial growth factors VEGF-B and VEGF-C are expressed in human tumors
31. Hyperplasia of lymphatic vessels in VEGF-C transgenic mice
32. The implications of angiogenesis for the biology and therapy of cancer metastasis
33. Apoptosis and tumor angiogenesis in cervical cancer after preoperative chemotherapy
34. Correlation between tumor angiogenesis and expression of thymidine phosphorylase, and patient outcome in uterine cervical carcinoma